Annexin A5 knockdown inhibits cardiomyocyte apoptosis and alleviates cardiac hypertrophy via activating the PI3K/AKT/Bcl-2 signaling pathway
Abstract Annexin A5 (ANXA5) is a small calcium-dependent protein that binds specifically to negatively charged phosphatidylserine as a marker of apoptosis. Previous studies have shown that ANXA5 expression is elevated in hypertensive patients and is closely related to left ventricular systolic funct...
Saved in:
Main Authors: | Lina Zhao, Hongjuan Cao, Yao Yuan, Chunyan Liao, Dan Huang, Xiaoyi Li, Yueyao Zhao, Quanfeng Huang, Sha Li, Bei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-12-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-83244-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Annexin A8 deficiency delays atherosclerosis progression
by: Carmen Gutiérrez‐Muñoz, et al.
Published: (2025-01-01) -
Different activation of MAPKs and Akt/GSK3β after preload vs. afterload elevation
by: Nico Hartmann, et al.
Published: (2022-06-01) -
Free fatty acid receptor 2 promotes cardiomyocyte hypertrophy by activating STAT3 and GATA4
by: Hui Gao, et al.
Published: (2022-03-01) -
The function and effect on prognosis of ANXA2 in gastric cancer peritoneal metastasis patients in cold region
by: Jin Shiyang, et al.
Published: (2025-01-01) -
EEPD1 attenuates radiation-induced cardiac hypertrophy and apoptosis by degrading FOXO3A in cardiomyocytes
by: Yu Kaiwen, et al.
Published: (2024-08-01)